טוען...
Glucose-responsive insulin and delivery systems: innovation and translation
Type 1 and advanced type 2 diabetes treatment involves daily injections or continuous infusion of exogenous insulin aimed at regulating blood glucose levels in the normoglycemic range. However, current options for insulin therapy are limited by the risk of hypoglycemia and are associated with subopt...
שמור ב:
| הוצא לאור ב: | Adv Mater |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141789/ https://ncbi.nlm.nih.gov/pubmed/31423670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adma.201902004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|